P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).

Authors

null

Shalini Subramaniam

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia

Shalini Subramaniam , Guy C. Toner , Martin R. Stockler , Andrew James Martin , Farzana D. Pashankar , A. Lindsay Frazier , Danish Mazhar , Kate Ford , Euan Thomas Walpole , Amanda Gwendolyn Stevanovic , David Wyld , Simon Troon , Fritha J. Hanning , Alison Jane Birtle , Matthew James Wheater , Robert A. Huddart , Jeff D. White , Sheri L. Spunt , Peter S. Grimison

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02582697

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr TPS425)

Abstract #

TPS425

Poster Bd #

N3

Abstract Disclosures